Key result
Patient-reported lack of symptom improvement is linked to ~66% higher death or HF risk vs marked improvement.
Why the study?
Symptom relief is a major goal in treating ADHF, but the relationship between patient-reported symptom change during hospitalization and subsequent prognosis needed investigation.
Does patient-reported perception of symptom change during hospitalization predict the composite of all-cause death or HF hospitalization in patients with acute decompensated heart failure?
Does patient-reported perception of symptom change during hospitalization predict the composite of all-cause death or HF hospitalization in patients with acute decompensated heart failure?
Patient-reported perception of symptom change at discharge is a significant predictor of 1-year all-cause mortality or heart failure hospitalization in patients with acute decompensated heart failure.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
May stratify 1-year risk in acute decompensated HF by symptom perception; supports prior observations but leaves practice change open.
Background The relief of the symptoms is one of the major purposes in the treatment for acute decompensated heart failure. The aim of this study is to investigate the relationship between patient-reported perception of symptom change of heart failure during hospitalization and subsequent prognosis in patients with acute decompensated heart failure (ADHF). Methods and Results Among 4056 consecutive patients hospitalized due to ADHF from a multicenter cohort study in Japan (Kyoto Congestive Heart Failure study), the study population consisted of 3567 patients who assessed their perception of symptom change during index hospitalization by themselves on 7-point Likert scale. We classified them the study patients into 4 groups: marked improvement group (N=1602; 44.9%), moderate improvement group (N=1659; 46.5%), minimal improvement group (N=240; 6.7%), and no improvement group (N=66; 1.9%). Primary outcome measures were a composite of all-cause death or HF hospitalization. The cumulative 1-year incidence of the primary outcome was higher in the no, minimal, and moderate improvement groups than in the marked improvement group (56%, 45%, 36%, vs 29%, log-rank P<0.001). After adjustment, the hazard ratios of the no, minimal, and moderate improvement groups relative to the marked improvement group were 1.66, 95% confidence interval [CI]: 1.14-2.42; 1.26, 95% CI: 1.01-1.57; 1.08, 95% CI: 0.95-1.21, respectively, for the primary outcome. Conclusion The patient-reported perception of symptom change at discharge was correlated with a composite of all-cause death or HF hospitalization at 1 year after discharge in patients admitted to the hospital for ADHF.
Matsuda et al. (2026) studied this question. Patient-reported no symptom improvement at discharge was associated with a 66% higher risk of death or HF hospitalization at 1 year compared to marked improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: